Archive for October, 2019

The Answer to Big Pharma’s Biggest Problem Could Double Your Money in just Three Years

0 | By Michael A. Robinson

You could forgive drug and biotech executives for having a bad case of target fixation.

After all, they do work in a field that is filled with time-consuming and expensive headaches.

Consider that the Biotechnology Innovation Organization (BIO), the world’s largest biotech trade organization, looked at 7,400 drug programs by 1,103 companies. They were investigating drug-approval rates.

The news was not good -just 9.6% of drugs scientists discover ever get approved for sale. That’s a one-in-ten shot.

With such daunting data, it’s no wonder that, even in a field already worth $1.2 trillion in global sales, industry leaders are on the lookout for ways to lower the cost of discovery and shorten time to market.

And with that goal in mind, I’ve uncovered a high-octane, large-cap firm that has become an essential ingredient in the drug sector’s success.

It’s a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure. It’s been doubling its earnings, on average, every 18 months

It’s a cloud-based leader in pharmaceutical efficiency that has a history of crushing the market by no small measure. It’s been doubling its earnings, on average, every 18 months

My Top Three Recommendations for New Investors

0 | By Michael A. Robinson

My “dad vibe” must be working overtime these days.

And that’s got me thinking maybe my “chance” conversations with a number of young adults lately is a sign of the times.

Let me explain.

As I’ve been going about my routines in the past, I’ve run into a lot of young people who want to get started in investing, but have no clue how to do so.

I’m talking about folks my daughters’ age who are earning some income and want to invest, but just don’t know where to start.

For instance, once, while skiing at the Kirkwood Mountain Resort near Lake Tahoe, I chatted with three young adults who jumped at the chance to get my advice about investing.

I guess that’s where the dad vibe comes into play…. I told them about a surefire way to make the market work for them as though I were talking to my own daughters.

And it just so happens that this investment advice is good for newcomers and old, particularly investors who’ve been reluctant to jump in when market conditions are so volatile.

That’s why today, I’m going to show you not just the one “starter” investment vehicle I suggest for young adults that can set you on the right track…

But I’m going to recommend three other tech-centric ways to jump start your portfolio right now…

Check it out

The “Printing” Tech Tackling Heart Disease’s $400 Billion in Annual Costs

0 | By Michael A. Robinson

There’s a new cutting-edge tech breakthrough that could save the lives of six million Americans in a decade.

Yes, it is potentially a very powerful weapon in the fight against heart disease, which the U.S. Centers for Disease Control and Prevention says causes one in four deaths each year.

Ironically, the technology is in a sector deeply out of favor with Wall Street.

But that’s just fine with us. At Strategic Tech Investor, we know the huge profit potential in bucking the Street’s herd mentality.

And you couldn’t pick a more exciting field than 3D-printed human organs.

Here’s the thing. Scientists in Israel printed a tiny heart in April, complete with blood vessels, using a patient’s cells.

Even better, they pulled off this amazing achievement in just three hours.

That’s why today, I’m going to show you what I believe is the best market-crushing play on the future of 3D printing tech used to save lives…

Check it out

The Backend Play that Could Give You Amazon’s Growth… at an 80% “Discount”

0 | By Michael A. Robinson

My daughters, ages 20 and 23, are a little bit bummed right now.

See, one of their favorite retail stores has just filed for bankruptcy protection. As a result, Forever 21 intends to close 178 stores in the U.S. and another 172 around the world.

Kendall and Jordan have been going to one of the local stores for many years. They like the wide selection of trendy clothes, shoes, and accessories at discount prices.

Here’s the thing: their other favorite place to shop continues to put lagging retailers under pressure to perform in the fast moving online world.

Growing up in a tech-centric home, both my daughters take shopping at Amazon.com Inc. (AMZN) as a given. Much to their dad’s chagrin, they do it all the time – and I do mean all the time.

But what most people miss here is that Amazon now relies on thousands of other companies to sell through the firm’s unbeatable storefront.

According to Statista, Amazon’s websites receive 209.7 million unique visitors every month from the U.S. alone, with most of the purchases they make coming from third-party sellers.

With that in mind, I want to show you why what I call Amazon’s “Hidden Supercharger” is set to crush the market

Why Wall Street Is Wrong About China and the Chip Sector, and Who is Leading the Rally

0 | By Strategic Tech Investor Staff

As fears of overexposure to the China trade dispute in the microchip and semiconductor sectors are being proven wrong, the market rallies. Investors are realizing that the banned Chinese company, Huawei, is not as tightly woven into those sectors as it had feared, and strong demand for chips will be driven on by the pending rollout of 5G technology. This means that those entire sectors are currently undervalued. As the new 5G upgrade cycle promises to keep demand high for years to come, there’s one company in this sector whose sales are up 24% since the market rally, and whose earnings are doubling nearly every three years – meaning huge growth potential if you latch on now. Click here to watch.

Despite Big Time Failures, IPOs Can Still Pay Off for You with this One Play

0 | By Michael A. Robinson

If all you did was look at the headlines, you’d think this is a terrible time to invest in initial public offerings (IPOs).

Just take a look at this recent riff from Forbes, “Why WeWork Won’t Work! – Hello Neumann!,” or Bloomberg’s announcement, “Endeavor Makes Last-Minute Call to Yank IPO as Conditions Sour.” Big time financial news is clearly in love with the idea that anyone getting hyped up for a big name IPO is just setting themselves up for disappointment.

On paper, that narrative makes sense.

WeWork’s attempt at an IPO saw an optimistic estimated valuation of $47 billion falling to less than $14 billion before the offering was abandoned entirely. The loss was so devastating that the CEO resigned over it.

Not only that, but Peloton Interactive Inc. (PTON) dropped 11.2% in its first day of trading on Sept. 26, a decline which, according to The Wall Street Journal, directly influenced the decision of talent firm, The Endeavor Group, to also put off its own new stock debut out of fear of poor market conditions.

But what the media isn’t telling you is that tech and life sciences firms are still IPO leaders. That segment of the market is actually doing quite well overall.

With that in mind, today I’m going to reveal why tech IPOs are so important to the market and show you how to profit from this lucrative trend

You Can Handle the Market’s Recent Chaos with These Two Techniques

0 | By Michael A. Robinson

Last week, I was in Las Vegas presenting at the first annual retreat of our sister operation, the National Institute for Cannabis Investors (NICI). While I was there, I realized just how many investors need to know what’s going on with the markets and the economy, and how they can be prepared for whatever chaos gets thrown at them.

The fact is, the S&P 500 was down on Oct. 2, up on Oct. 4, down on Oct. 8, and up again yesterday. The situation is crazier than ever.

That’s why it’s time to buckle up and learn the tools you’ll need to protect your profits in a sideways market.

The key to staying afloat will be your skills at portfolio management. Inparticular, you’ll need two of my favorite techniques that are perfect for times like these.

But before I talk about our savvy portfolio management tools that have helped us absolutely shred the market, let’s take a look at why this chaos happening in the first place

This Aerospace Play Can Bank You Lofty Profits from NASA’s Lofty Goals

0 | By Michael A. Robinson

Just a little more than three months ago, we celebrated the 50th anniversary of one of the great technical achievements in the history of the human race.

It was on July 20, 1969 that Neil Armstrong became the first person to set foot on the moon.

And what could be a better way to celebrate that accomplishment than to follow that up with another lunar mission?

No, we’re not going to land there tomorrow or even next year for that matter. Fact is, the U.S. probably won’t return to the moon for another decade.

So, why am I celebrating already? Fair question. The answer: a storied space pioneer just received a huge order from NASA to build up to 12 Orion spacecraft.

Known as Artemis, the new lunar program could mean at least $4.6 billion in revenue for this aerospace leader, and massive payouts for you.

And today, I’m going to show you why this fact means the stock will continue to crush the market and lift investors’ portfolios for years to come

Cash in on the Most Disruptive Tech on the Market with Only One Investment

0 | By Michael A. Robinson

I have to say, I’m not surprised to see a high-octane fintech startup become a huge “unicorn.”

By “unicorn” I mean a privately held firm with a pre-IPO valuation in excess of $1 billion.

Then again, Stripe Inc. is really onto something. The firm’s technology serves as a great digital payments gateway. Wall Street and Silicon Valley are clearly impressed.

Stripe recently received fresh funding of roughly $250 million from the venture capital firms Sequoia Capital, General Catalyst, and Andreessen Horowitz.

After that cash haul, Stripe is now valued at $35 billion, making it one of the world’s most valuable startups.

It’s easy to see why Stripe is so well positioned to succeed. Adapt Insights says the global fintech payments market is already worth $4.8 trillion.

Don’t worry. To cash in on this highly lucrative field, you don’t have to strike a private deal or wait for a company like Stripe to go public.

Today, I’m going to reveal a way you can invest in the entire sector with one move that is beating the market by more than 70%

The Small-Cap Backend Cannabis Play Set to Disrupt a $1.2 Trillion Global Industry

0 | By Michael A. Robinson

I’m having a great day – nothing hurts.

Trust me, that’s no minor thing in my life. See, I’ve suffered from chronic lower back pain since I was 15 and my neck has hurt since my early 20s.

For years, I have relied on Advil Liqui-Gels and Biofreeze menthol rub for daytime relief. I also took muscle relaxants to combat night spasms that would keep me awake.

However, those pains are quickly becoming just memories because I have found what is, so far, giving me amazing results.

It’s a substance the human race has used for centuries. It’s all natural and very effective. It’s also a compound that is sweeping 33 states and the District of Columbia.

Of course, I’m talking about cannabis.

Make no mistake, the substance that used to be demonized in the U.S has great medicinal properties.

In fact, I’ll be talking about how to profit from medical aspects of marijuana at the National Institute for Cannabis Investors (NICI) in Las Vegas on Thursday.

With that in mind, I’d like to offer you a preview of my talk and reveal a unique, high-yield cannabis investment